Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
INR | Fiscal Year Ending | | Latest |
(in millions) | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 209 | 306 | 340 | 540 | 438 | 458 | 424 | 480 | 494 | 824 | | 833 |
% Growth | NA | 46.3% | 11.3% | 58.7% | -18.8% | 4.6% | -7.4% | 13.1% | 2.9% | 66.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | (164) | (227) | (203) | (403) | (295) | (324) | (308) | (347) | (445) | (721) | | (683) |
Gross Profit | 45 | 79 | 137 | 137 | 143 | 134 | 116 | 133 | 49 | 103 | | 151 |
% Revenue | 21.7% | 25.8% | 40.3% | 25.4% | 32.7% | 29.2% | 27.4% | 27.7% | 9.9% | 12.5% | | 18.1% |
| | | | | | | | | | | | |
Research and Development | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | | (0) |
Selling and Marketing | (3) | (2) | (3) | (3) | (4) | (3) | (3) | (2) | (4) | (5) | | (5) |
General and Admin | (13) | (26) | (26) | (24) | (28) | (26) | (21) | (23) | (27) | (29) | | (31) |
Other Inc / (Exp) | (19) | (25) | (45) | (34) | (29) | (24) | (33) | (39) | (85) | (35) | | (82) |
Total Operating Exp | (35) | (53) | (74) | (61) | (61) | (54) | (57) | (64) | (115) | (69) | | (118) |
| | | | | | | | | | | | |
Operating Income | 11 | 26 | 63 | 75 | 83 | 80 | 59 | 69 | (67) | 34 | | 33 |
% Revenue | 5.0% | 8.4% | 18.5% | 14.0% | 18.8% | 17.4% | 14.0% | 14.3% | -13.5% | 4.1% | | 3.9% |
| | | | | | | | | | | | |
Interest Expense | (7) | (15) | (38) | (42) | (51) | (48) | (39) | (42) | 103 | 20 | | 15 |
Pre-tax Income | 3 | 11 | 25 | 33 | 31 | 32 | 20 | 26 | 37 | 53 | | 47 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (3) | (3) | (6) | (8) | (6) | (5) | (4) | (7) | (10) | (14) | | (12) |
Net Income to Company | 1 | 7 | 18 | 25 | 25 | 27 | 17 | 20 | 27 | 39 | | 35 |
% Margin | 0.4% | 2.4% | 5.4% | 4.6% | 5.8% | 5.8% | 3.9% | 4.1% | 5.4% | 4.7% | | 4.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 1 | 7 | 18 | 25 | 25 | 27 | 17 | 20 | 27 | 39 | | 35 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 1 | 7 | 18 | 25 | 25 | 27 | 17 | 20 | 27 | 39 | | 35 |
% Margin | 0.4% | 2.4% | 5.4% | 4.6% | 5.8% | 5.8% | 3.9% | 4.1% | 5.4% | 4.7% | | 4.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.11 | 1.10 | 1.29 | 1.73 | 1.78 | 1.87 | 1.17 | 1.39 | 1.89 | 2.76 | | 2.47 |
Diluted EPS (Continuing Ops) | 0.11 | 1.10 | 1.29 | 1.73 | 1.78 | 1.87 | 1.17 | 1.39 | 1.89 | 2.76 | | 2.47 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 6.81 | 6.71 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | | 14.25 |
WA Diluted Shares Out. | 6.81 | 6.71 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | 14.19 | | 14.25 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 3 | 11 | 25 | 33 | 31 | 32 | 20 | 26 | 37 | 53 | | 47 |
Addback: Net Interest Expense | 7 | 15 | 38 | 42 | 51 | 48 | 39 | 42 | (103) | (20) | | (15) |
Addback: Other Non Operating Expenses, Total | 3 | 6 | 3 | 1 | 1 | 2 | 0 | 2 | 5 | (1) | | 43 |
Addback: Depreciation & Amortization | 4 | 3 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 6 | | 7 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 1 | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | (1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 18 | 35 | 70 | 80 | 87 | 86 | 65 | 76 | (57) | 39 | | 82 |
% Margin | 8.5% | 11.4% | 20.5% | 14.8% | 19.9% | 18.8% | 15.2% | 15.8% | -11.5% | 4.7% | | 9.9% |
| | | | | | | | | | | | |
Adjusted EBIT | 14 | 32 | 66 | 76 | 83 | 82 | 60 | 71 | (61) | 33 | | 76 |
% Margin | 6.5% | 10.4% | 19.4% | 14.1% | 19.0% | 17.9% | 14.1% | 14.9% | -12.4% | 4.0% | | 9.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 1 | 7 | 18 | 25 | 25 | 27 | 17 | 20 | 27 | 39 | | 35 |
Addback: Unusual Items | 0 | (0) | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | | 0 |
Adjusted Net Income | 1 | 7 | 18 | 25 | 25 | 27 | 17 | 20 | 27 | 39 | | 35 |
% Margin | 0.4% | 2.4% | 5.4% | 4.6% | 5.8% | 5.8% | 3.9% | 4.1% | 5.5% | 4.7% | | 4.2% |